benzylideneacetone has been researched along with methyl-3-methoxy-4-hydroxystyryl ketone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastow, KF; Itokawa, H; Lee, KH; Nakagawa-Goto, K; Nakamura, S; Tatsuzaki, J | 1 |
| Hampannavar, GA; Karpoormath, R; Palkar, MB; Shaikh, MS | 1 |
| Ashihara, Y; Motohashi, N; Saito, Y; Yamagami, C | 1 |
1 review(s) available for benzylideneacetone and methyl-3-methoxy-4-hydroxystyryl ketone
| Article | Year |
|---|---|
An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents, Phytogenic; Antioxidants; Curcumin; Drug Design; Humans; Molecular Structure; Platelet Aggregation Inhibitors; Styrenes; Zingiber officinale | 2016 |
2 other study(ies) available for benzylideneacetone and methyl-3-methoxy-4-hydroxystyryl ketone
| Article | Year |
|---|---|
Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chalcones; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Eugenol; Humans; Inhibitory Concentration 50; Molecular Structure; Styrenes; Tumor Cells, Cultured | 2006 |
Antimutagenic effects of dehydrozingerone and its analogs on UV-induced mutagenesis in Escherichia coli.
Topics: Acrolein; Antimutagenic Agents; Butanones; Escherichia coli; Gamma Rays; Mutagenesis; Styrenes; Ultraviolet Rays | 1997 |